UNSPSC 85819326: Transfusion of nonautologous frozen red cells into peripheral vein, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to transfusion of nonautologous frozen red cells into peripheral vein, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 30233P1

UNSPSC 85819326 Transfusion of nonautologous frozen red cells into peripheral vein, percutaneous approach is a Commodity code that shows little relevant recent activity under state and local procurement. The recent opportunities tagged to this code span independent medical evaluations for disability benefit determinations, surgical carve-out benefits for municipal employees, occupational health surveillance, youth detention medical services, pharmacy benefit management, and temporary health professional staffing — none of which align with the code's nominal scope of blood-product transfusion services. State and local procurement offices do not appear to be soliciting transfusion services themselves under this classification; the mismatch suggests either systematic miscoding of health-related medical services into this taxonomy or that the code itself does not reflect active state and local demand for the product it nominally describes.

The issuing bodies in the recent opportunities include city retirement offices (Phoenix), municipal health plans (Long Beach), state transportation agencies (Washington), county juvenile probation departments (Harris County), county health systems (Santa Clara), and county benefits consortia (Collier County) — a wide range of public entities with health and human services mandates. Activity appears across Arizona, California, Washington, Florida, and Texas. No opportunities in the dataset represent actual procurement of blood products or transfusion administration services, and no repeat buyers emerge under this code. Given the disconnect between the code definition and the work being bought, pursuit of this code is not recommended for firms offering transfusion or blood-product services.